EGFR-targeting, β-defensin-tailored fusion protein exhibits high therapeutic efficacy against EGFR-expressed human carcinoma via mitochondria-mediated apoptosis
Wenjuan Liu(St. Michael's Hospital), Yong‐Su Zhen(Chinese Academy of Medical Sciences & Peking Union Medical College)
Cited by 24
Related Papers
Inhibition of histone deacetylases by trans-cinnamic acid and its antitumor effect against colon cancer xenografts in athymic mice
|Molecular Medicine Reports|2016|71
Combined Oral Administration of GABA and DPP-4 Inhibitor Prevents Beta Cell Damage and Promotes Beta Cell Regeneration in Mice
|Frontiers in Pharmacology|2017|50
Spironolactone Protects against Diabetic Cardiomyopathy in Streptozotocin-Induced Diabetic Rats
|Journal of Diabetes Research|2018|44
A Novel Nitrobenzoate Microtubule Inhibitor that Overcomes Multidrug Resistance Exhibits Antitumor Activity
|Scientific Reports|2016|35
Mithramycin-loaded mPEG-PLGA nanoparticles exert potent antitumor efficacy against pancreatic carcinoma
|International Journal of Nanomedicine|2017|28